In particular, intracellular NAMPT overexpression and increased eNAMPT levels were described in several metabolic and inflammatory disorders, including obesity, T2DM, atherogenic inflammatory diseases, and inflammatory bowel disease [10], while molecular mechanisms associated with intracellular NAPRT expression and eNAPRT secretion are less known. Here, NAPRT is linked to type 2 diabetes mellitus.